DK1019066T3 - Fremgangsmåder og præparater til forebyggelse og behandling af halsbrand - Google Patents

Fremgangsmåder og præparater til forebyggelse og behandling af halsbrand

Info

Publication number
DK1019066T3
DK1019066T3 DK97945263T DK97945263T DK1019066T3 DK 1019066 T3 DK1019066 T3 DK 1019066T3 DK 97945263 T DK97945263 T DK 97945263T DK 97945263 T DK97945263 T DK 97945263T DK 1019066 T3 DK1019066 T3 DK 1019066T3
Authority
DK
Denmark
Prior art keywords
heartburn
preparations
prevention
treatment
methods
Prior art date
Application number
DK97945263T
Other languages
Danish (da)
English (en)
Inventor
Scott H Korn
Gerard P Mcnally
Joseph R Luber
Tom S Ells
Original Assignee
Merck & Co Inc
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9624291.2A external-priority patent/GB9624291D0/en
Application filed by Merck & Co Inc, Mcneil Ppc Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK1019066T3 publication Critical patent/DK1019066T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK97945263T 1996-10-04 1997-09-30 Fremgangsmåder og præparater til forebyggelse og behandling af halsbrand DK1019066T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2765996P 1996-10-04 1996-10-04
GBGB9624291.2A GB9624291D0 (en) 1996-11-22 1996-11-22 Methods and compositions for preventions and treating heartburn
PCT/US1997/017083 WO1998014198A1 (en) 1996-10-04 1997-09-30 Methods and compositions for preventing and treating heartburn

Publications (1)

Publication Number Publication Date
DK1019066T3 true DK1019066T3 (da) 2007-02-26

Family

ID=26310458

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97945263T DK1019066T3 (da) 1996-10-04 1997-09-30 Fremgangsmåder og præparater til forebyggelse og behandling af halsbrand

Country Status (9)

Country Link
EP (1) EP1019066B1 (de)
JP (1) JP2001501224A (de)
AT (1) ATE345138T1 (de)
AU (1) AU728423B2 (de)
CA (1) CA2267503C (de)
DE (1) DE69736955T2 (de)
DK (1) DK1019066T3 (de)
ES (1) ES2274550T3 (de)
WO (1) WO1998014198A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080248136A1 (en) * 2006-10-25 2008-10-09 Iomedix Development International Srl Acute and chronic heartburn composition and method
WO2017091166A1 (en) 2015-11-26 2017-06-01 Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. Stable pharmaceutical compositions and process for their preparation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1363399A (en) * 1972-04-13 1974-08-14 Rotta Research Lab Method of preparing an antacid pharmaceutical product
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
US4486412A (en) * 1983-03-15 1984-12-04 Pharmacaps, Inc. Encapsulated antacid dispersions
CA1239349A (en) * 1983-10-10 1988-07-19 Eberhard F. Gottwald Pharmaceutical composition containing cimetidine
EP0179858B1 (de) * 1984-04-19 1992-07-01 Rhone-Poulenc Rorer International (Holdings) Inc. Antisäurezusammensetzung
IE58636B1 (en) * 1984-10-17 1993-10-20 American Home Prod Fluidized and rehydratable magaldrate compositions
US4744986A (en) * 1986-03-07 1988-05-17 Rorer Pharmaceutical Corporation Process for the preparation of a viscosity-stable antacid composition
EP0294933B1 (de) * 1987-05-08 1992-03-11 Smith Kline & French Laboratories Limited Pharmazeutische Zusammensetzungen
KR960011236B1 (ko) * 1987-05-08 1996-08-21 스미스 클라인 앤드 프렌취 라보라토리스 리미티드 제약학적 조성물 및 고체 제형
US4988679A (en) * 1989-01-03 1991-01-29 Leonard Chavkin Liquid sustained release composition
US5299137A (en) * 1990-04-05 1994-03-29 Vlsi Technology, Inc. Behavioral synthesis of circuits including high impedance buffers
AU7981391A (en) * 1990-06-22 1992-01-23 Beecham Group Plc Novel treatment
CA2055661A1 (en) * 1990-12-21 1992-06-22 Manley A. Paulos Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn
CA2110313C (en) * 1992-12-01 2004-10-26 Edward John Roche Pharmaceutical compositions containing a guanidinothiazole compound and antacids
AU7255094A (en) * 1993-07-06 1995-02-06 Mcneil-Ppc, Inc. H2 antagonist-antihistamine combinations
JPH08512321A (ja) * 1993-07-06 1996-12-24 メルク エンド カンパニー インコーポレーテッド Ｈ▲下２▼拮抗剤−アルギネート−制酸剤の組合せ物
IT1264546B1 (it) * 1993-07-30 1996-10-02 Lisapharma Spa Composizione farmaceutica ad attivita' antiacida in forma di sospensione a base di gel di sucralfato
US5667794A (en) * 1995-05-02 1997-09-16 Merck & Co., Inc. Heartburn treatment

Also Published As

Publication number Publication date
CA2267503A1 (en) 1998-04-09
CA2267503C (en) 2002-04-30
EP1019066B1 (de) 2006-11-15
DE69736955D1 (de) 2006-12-28
AU4650697A (en) 1998-04-24
AU728423B2 (en) 2001-01-11
DE69736955T2 (de) 2007-07-12
JP2001501224A (ja) 2001-01-30
ATE345138T1 (de) 2006-12-15
ES2274550T3 (es) 2007-05-16
EP1019066A4 (de) 2000-07-19
WO1998014198A1 (en) 1998-04-09
EP1019066A1 (de) 2000-07-19

Similar Documents

Publication Publication Date Title
CA2285203A1 (en) Compositions containing capsaicin or capsaicin analogues and a local anesthetic
DE69738667D1 (de) Vorbeugung und behandlung von kolonadenom oder kolonmikroadenom mit 6-fluorursodeoxycholsäure
WO1999064059A3 (en) Use of secretin for the treatment of autism and other neurological, behavioral and immunological disorders
MY106528A (en) Method of treating impotence.
EP0866656A4 (de) Inhibierung des alpha tumornekrose-faktors
MX9706957A (es) Composicion que contiene amlodipina, o una sal, o felodipina y un inhibidor de enzima convertidora de angiotensina.
MY118986A (en) Use of (alpha)-1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
SE9603725D0 (sv) New teatment
WO2002026245A3 (en) Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
CA2156481A1 (en) 5-ht2 receptor antagonist compositions useful in treating venous conditions
MY126321A (en) Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer.
SE9902597D0 (sv) New use
EP0744176A3 (de) Arzneimittel zur Hemmung von Knochenschwund
DK1019066T3 (da) Fremgangsmåder og præparater til forebyggelse og behandling af halsbrand
EP1073436A4 (de) Verbesserte methode zur ausrottung von helicobacter pylori
AU4937499A (en) Use of succinic acid or salts thereof and method of treating insulin resistance
NO985695L (no) Formulering og fremgangsmÕte for Õ behandle kongestiv hjerteinfarkt
IL126158A0 (en) Method for treating substance abuse
EP0790250A3 (de) Inhibitoren des biogenen Amin Transportes
WO2000010590A3 (en) Cancer treatment
ZA945431B (en) Use of benzydamine in the treatment of pathological conditions caused by TNF
WO2001039760A3 (en) Method of treating batten disease
CA2341891A1 (en) The use of r(+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of sleep disorders
MD1296F1 (en) The Nicolau method of treatment of the lichen planus
MD1469F1 (en) Method of treatment of the burn shock